Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10.

García-Prieto E, González-López A, Cabrera S, Astudillo A, Gutiérrez-Fernández A, Fanjul-Fernandez M, Batalla-Solís E, Puente XS, Fueyo A, López-Otín C, Albaiceta GM.

PLoS One. 2010 Oct 7;5(10):e13242. doi: 10.1371/journal.pone.0013242.

2.

Generation of bleomycin-induced lung fibrosis is independent of IL-16.

Glass WG, Argentieri RL, Bracht M, Farrell FX, Das AM, Del Vecchio AM, Hogaboam CM, Murray LA.

Cytokine. 2009 Apr;46(1):17-23. doi: 10.1016/j.cyto.2008.11.007. Epub 2009 Feb 15.

PMID:
19232499
3.

Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Craig VJ, Quintero PA, Fyfe SE, Patel AS, Knolle MD, Kobzik L, Owen CA.

J Immunol. 2013 Apr 15;190(8):4283-96. doi: 10.4049/jimmunol.1201043. Epub 2013 Mar 13.

4.

Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.

Huaux F, Liu T, McGarry B, Ullenbruch M, Xing Z, Phan SH.

J Immunol. 2003 Nov 15;171(10):5470-81.

5.

Disruption of tumor necrosis factor receptor p55 impairs collagen turnover in experimentally induced sclerodermic skin fibroblasts.

Murota H, Hamasaki Y, Nakashima T, Yamamoto K, Katayama I, Matsuyama T.

Arthritis Rheum. 2003 Apr;48(4):1117-25.

6.

IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.

Kradin RL, Sakamoto H, Jain F, Zhao LH, Hymowitz G, Preffer F.

Exp Mol Pathol. 2004 Jun;76(3):205-11.

PMID:
15126102
7.

Bleomycin-induced pulmonary fibrosis is independent of eosinophils.

Hao H, Cohen DA, Jennings CD, Bryson JS, Kaplan AM.

J Leukoc Biol. 2000 Oct;68(4):515-21.

PMID:
11037973
8.

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Zhu Y, Liu Y, Zhou W, Xiang R, Jiang L, Huang K, Xiao Y, Guo Z, Gao J.

Respir Res. 2010 Mar 20;11:34. doi: 10.1186/1465-9921-11-34.

9.

Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury.

Albaiceta GM, Gutierrez-Fernández A, García-Prieto E, Puente XS, Parra D, Astudillo A, Campestre C, Cabrera S, Gonzalez-Lopez A, Fueyo A, Taboada F, López-Otin C.

Am J Respir Cell Mol Biol. 2010 Nov;43(5):555-63. doi: 10.1165/rcmb.2009-0034OC. Epub 2009 Dec 7.

PMID:
19995943
10.

The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.

Manoury B, Nenan S, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V.

Respir Res. 2005 Jan 21;6:11.

11.

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.

Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, Matsushima S, Torii M, Arimura A.

Eur J Pharmacol. 2008 Aug 20;590(1-3):400-8. doi: 10.1016/j.ejphar.2008.06.046. Epub 2008 Jun 16.

PMID:
18598692
12.

Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.

Tabata C, Tabata R, Kadokawa Y, Hisamori S, Takahashi M, Mishima M, Nakano T, Kubo H.

J Immunol. 2007 Jul 1;179(1):708-14.

13.

The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.

Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA.

Am J Pathol. 2000 Jul;157(1):177-87.

14.

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.

Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A.

Am J Pathol. 2009 Jul;175(1):303-13. doi: 10.2353/ajpath.2009.080629. Epub 2009 Jun 4.

15.

Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis.

Banerjee ER, Henderson WR Jr.

Stem Cell Res Ther. 2012 May 29;3(3):21. doi: 10.1186/scrt112.

16.

Dual roles of IL-4 in lung injury and fibrosis.

Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH.

J Immunol. 2003 Feb 15;170(4):2083-92.

17.

Complex regulation of pulmonary inflammation and fibrosis by CCL18.

Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP.

Am J Pathol. 2007 Aug;171(2):428-37. Epub 2007 Jun 14.

18.

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

Unemori EN, Pickford LB, Salles AL, Piercy CE, Grove BH, Erikson ME, Amento EP.

J Clin Invest. 1996 Dec 15;98(12):2739-45.

19.

Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.

Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, Fenoglio C, Perlini S, Pozzi E.

Eur J Histochem. 2006 Oct-Dec;50(4):317-25.

PMID:
17213041
20.

The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions.

Ovet H, Oztay F.

Biol Trace Elem Res. 2014 Dec;162(1-3):189-99. doi: 10.1007/s12011-014-0142-1. Epub 2014 Oct 28.

PMID:
25349139

Supplemental Content

Support Center